Literature DB >> 19382256

Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya.

Erwan Piriou1, Rhonda Kimmel, Kiprotich Chelimo, Jaap M Middeldorp, Peter Sumba Odada, Robert Ploutz-Snyder, Ann M Moormann, Rosemary Rochford.   

Abstract

To study the long term the effects of chronic exposure to P. falciparum malaria on Epstein-Barr virus (EBV) reactivation in children, EBV-specific antibody levels were measured in a cross-sectional survey of two groups of Kenyan children with divergent malaria exposure, varying in age from 1 to 14 years. A total of 169 children were analyzed within three age groups (1-4 years, 5-9 years and 10-14 years). Using a Luminex assay, elevated levels of IgG to EBV lytic and latent antigens were observed in children from the holoendemic malaria area; these remained elevated for each age group studied. In comparison, children from the sporadic malaria area had lower levels of EBV-specific IgG antibodies and these levels declined across age groups. These data suggest that chronic exposure to malaria may lead to long-term EBV reactivation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19382256      PMCID: PMC3134942          DOI: 10.1002/jmv.21485

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  21 in total

1.  EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.

Authors:  Kwok H Chan; Yao L Gu; Fai Ng; Park S P Ng; Wing H Seto; Jonathan S T Sham; Daniel Chua; William Wei; Yue L Chen; Winsie Luk; Yong S Zong; Mun H Ng
Journal:  Int J Cancer       Date:  2003-07-10       Impact factor: 7.396

2.  AN EPIDEMIOLOGIC APPROACH TO THE LYMPHOMAS OF AFRICAN CHILDREN AND BURKITT'S SACROMA OF THE JAWS.

Authors:  G DALLDORF; C A LINSELL; F E BARNHART; R MARTYN
Journal:  Perspect Biol Med       Date:  1964       Impact factor: 1.416

3.  New multiplexed flow cytometric assay to measure anti-peptide antibody: a novel tool for monitoring immune responses to peptides used for immunization.

Authors:  N Komatsu; S Shichijo; M Nakagawa; K Itoh
Journal:  Scand J Clin Lab Invest       Date:  2004       Impact factor: 1.713

4.  Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study.

Authors:  G de-Thé; A Geser; N E Day; P M Tukei; E H Williams; D P Beri; P G Smith; A G Dean; G W Bronkamm; P Feorino; W Henle
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

5.  Burkitt's lymphoma and malaria.

Authors:  G W Kafuko; D P Burkitt
Journal:  Int J Cancer       Date:  1970-07-15       Impact factor: 7.396

6.  Burkitt's lymphoma in Kenya: geographical, age, gender and ethnic distribution.

Authors:  O W Mwanda; R Rochford; A M Moormann; A Macneil; C Whalen; M L Wilson
Journal:  East Afr Med J       Date:  2004-08

7.  The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes.

Authors:  R Tedeschi; Y T Foong; H M Cheng; P dePaoli; T Lehtinen; T Elfborg; J Dillner
Journal:  J Gen Virol       Date:  1995-06       Impact factor: 3.891

8.  Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus.

Authors:  M A Rahman; L A Kingsley; R W Atchison; S Belle; M C Breinig; M Ho; C R Rinaldo
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

9.  Final case reporting from the Ugandan prospective study of the relationship between EBV and Burkitt's lymphoma.

Authors:  A Geser; G de Thé; G Lenoir; N E Day; E H Williams
Journal:  Int J Cancer       Date:  1982-04-15       Impact factor: 7.396

10.  Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study.

Authors:  Nora Mutalima; Elizabeth Molyneux; Harold Jaffe; Steve Kamiza; Eric Borgstein; Nyengo Mkandawire; George Liomba; Mkume Batumba; Dimitrios Lagos; Fiona Gratrix; Chris Boshoff; Delphine Casabonne; Lucy M Carpenter; Robert Newton
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  28 in total

1.  Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma.

Authors:  Erwan Piriou; Amolo S Asito; Peter O Sumba; Nancy Fiore; Jaap M Middeldorp; Ann M Moormann; Robert Ploutz-Snyder; Rosemary Rochford
Journal:  J Infect Dis       Date:  2012-02-01       Impact factor: 5.226

2.  The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma.

Authors:  Anna E Coghill; Carla Proietti; Allan Hildesheim; Denise L Doolan; Sam M Mbulaiteye; Zhiwei Liu; Lutz Krause; Jeff Bethony; Ludmila Prokunina-Olsson; Adeola Obajemu; Francis Nkrumah; Robert J Biggar; Kishor Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-16       Impact factor: 4.254

Review 3.  The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma.

Authors:  Ann M Moormann; Cynthia J Snider; Kiprotich Chelimo
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

4.  Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya.

Authors:  Ibrahim I Daud; Sidney Ogolla; Asito S Amolo; Eunice Namuyenga; Kenneth Simbiri; Elizabeth A Bukusi; Zipporah W Ng'ang'a; Robert Ploutz-Snyder; Peter O Sumba; Arlene Dent; Rosemary Rochford
Journal:  Matern Child Health J       Date:  2015-03

5.  Longevity of Genotype-Specific Immune Responses to Plasmodium falciparum Merozoite Surface Protein 1 in Kenyan Children from Regions of Different Malaria Transmission Intensity.

Authors:  Natalie M Bowman; Jonathan J Juliano; Cynthia J Snider; Oksana Kharabora; Steven R Meshnick; John Vulule; Chandy C John; Ann M Moormann
Journal:  Am J Trop Med Hyg       Date:  2016-08-01       Impact factor: 2.345

6.  Incidence of Endemic Burkitt Lymphoma in Three Regions of Mozambique.

Authors:  Cristina O'Callaghan-Gordo; Delphine Casabonne; Carla Carrilho; Josefo Ferro; Cesaltina Lorenzoni; Clesio Zaqueu; Augusto Nhabomba; Ruth Aguilar; Quique Bassat; Sílvia de Sanjosé; Carlota Dobaño; Manolis Kogevinas
Journal:  Am J Trop Med Hyg       Date:  2016-10-31       Impact factor: 2.345

7.  Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection.

Authors:  Arnold Reynaldi; Timothy E Schlub; Erwan Piriou; Sidney Ogolla; Odada P Sumba; Ann M Moormann; Rosemary Rochford; Miles P Davenport
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 5.226

Review 8.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

9.  Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study.

Authors:  Amolo S Asito; Erwan Piriou; Peter Sumba Odada; Nancy Fiore; Jaap M Middeldorp; Carole Long; Sheetij Dutta; David E Lanar; Walter G Jura; Collins Ouma; Juliana A Otieno; Ann M Moormann; Rosemary Rochford
Journal:  Infect Agent Cancer       Date:  2010-07-28       Impact factor: 2.965

10.  Development of whole-virus multiplex luminex-based serological assays for diagnosis of infections with kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 homologs in macaques.

Authors:  Jonathan T Ryan; Timothy M Rose
Journal:  Clin Vaccine Immunol       Date:  2013-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.